The sleep apnea clinical trial analysis report delivers important insights into ongoing research of 24+ pipeline sleep apnea drugs, clinical strategies, upcoming therapeutics, and commercial analysis.
(RTTNews) - Nyxoah SA (NYXH), a medical technology company specializing in innovative treatments for Obstructive Sleep Apnea (OSA), announced the successful implantation of its Genio system in the ...
Sleep-apnea-treatment neuromodulation company Nyxoah says former Teleflex CEO Liam Kelly will take over its corner office, ...
CAMBRIDGE, Mass., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep ...
NEW YORK and SAN FRANCISCO, June 26, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ('Dario' or the 'Company'), a leader in the global digital health market, today announced a strategic ...
Credit: Getty Images Obstructive sleep apnea may significantly increase the risk for coronary artery disease, atrial fibrillation, cerebrovascular accident, and congestive heart failure. Obstructive ...
Sleep Better Marysville has announced the expansion of its sleep apnea treatment services in the Marysville, Ohio area, increasing access to noninvasive solutions for individuals diagnosed with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results